Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

• Bruno de Paula,
• Olivier Cexus,
• Paul Townsend,
• Susanne Crocamo

Affiliations

Bruno de Paula

Corresponding author. School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK.; School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK; Núcleo de Pesquisa Clínica, Hospital do Câncer III, Instituto Nacional de Câncer – INCA, Brazil

Olivier Cexus

School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK

Paul Townsend

School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK

Susanne Crocamo

Núcleo de Pesquisa Clínica, Hospital do Câncer III, Instituto Nacional de Câncer – INCA, Brazil